We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Prioritizes Review of Nalmefene Prefilled Syringe for Opioid Overdose
FDA Prioritizes Review of Nalmefene Prefilled Syringe for Opioid Overdose
The FDA has granted a priority review for Purdue’s abbreviated new drug application for nalmefene prefilled syringes for complete or partial reversal of opioid overdose.